Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsIndonesia is striving to tackle the COVID-19 outbreak with domestically produced innovations, but researchers say the government may face roadblocks in the mass production of such products because of the absence of pro-innovation policies.
State-owned Indonesian pharmaceutical company Kimia Farma imported 300,000 testing kits early in April from a pharmaceutical company in Apeldoorn, the Netherlands, called Inzek International Trading BV.
The Research and Technology Ministry's consortium for COVID-19 studies has pushed for the development of domestically produced medical equipment to boost the country's battle against the pandemic.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.